Helen Matthews COO at The Cure Parkinson’s Trust said: “At CPT, we are leaving no stone unturned in our quest to find new treatments that will slow, stop or reverse Parkinson’s. We want to make a difference to people living with this condition. Simvastatin was prioritised by our LCT committee in 2012 and we are delighted to have progressed this forward to trial."

Read more here...